Meningococcal Vaccines Market - Global Industry Analysis

Meningococcal Vaccines Market

Global Meningococcal Vaccines Market Industry Size, Share, Applications, Trends, Growth, Analysis and Forecast 2028

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4775 Published Date: Sep-2019 Status : Published
Market Size in 2018 Market Forecast in 2025 Growth Rate (in %) Base Year
USD 3,833 Million USD 8,295 Million CAGR at 11.73%. 2018

Table Of Content

Methodology

Free Analysis

Meningococcal vaccine treats meningitidis that is caused by bacteria N. These vaccines are administered via injections. In nations with low illness danger, they suggest immunizing high-risk groups. Generally, meningococcal vaccines are secure, but some individuals may feel pain and redness at the injection site. However, in less than one in a million doses, severe allergic responses are recorded.

Developing nations like Brazil, Russia, India, China, and South Africa are progressively engaged in improvising and expanding their health infrastructure along with investing heavily in innovation in health, progressively impacting the health procedures worldwide. Thus, to develop innovative health technologies, the Indian government is increasingly investing in the early phase of different research and development projects. Therefore, high-quality, low-cost vaccines produced by developing countries are likely to drive the meningococcal vaccines market. Furthermore, rising awareness about the meningococcal vaccines is also fuelling the meningococcal vaccines market development. Many leading companies are collaborating with non-profit organizations to create awareness about the disease and its various treatment options for meningococcal infections. Visits to healthcare facilities should be used to evaluate the status of immunization and administer suggested vaccines to allow maximum number of adolescents access to these vaccines. Alternative sites can also be used to maximize vaccination possibilities, such as colleges or pharmacies.

Global Meningococcal Vaccines Market

The meningococcal vaccines market is fragmented into type and end-user. Based on type, the market is classified into combination (MenHibrix and Menitorix), polysaccharide (NmVac4, Mencevax, Menomune, and others), conjugate (Menjugate, Nimenrix, Menveo, Menactra, NeisVac-C, MenAfriVac, Meningitec, and NmVac4-DT), and Men B vaccines (Bexsero and Trumenba). The end-user segment is classified into hospital pharmacies, retail pharmacies, and others.

North America is anticipated to lead the meningococcal vaccines market worldwide, owing to the increasing public measures and prevention programs and research and growth projects by multiple regional producers. Group-B vaccines have been custom-made for particular epidemic strains and are widely used in Cuba, Brazil, New Zealand, France, Chile, and Norway. In developed nations like Australia, Canada, and certain European countries, the incidence of meningococcal illnesses decreased before the advent of the vaccine, which further accelerated the disease's decline. This is followed by the regions of Latin America and the Middle East and Africa. Due to low production costs and increased healthcare expenditure, the Asia Pacific region is anticipated to be the fastest-growing in the meningococcal vaccines market.

Some key players of the meningococcal vaccines market are Novartis International, Nuron Biotech, GlaxoSmithKline, Pfizer, Sanofi, JN-International Medical, Baxter International, Serum Institute of India, and Biomed.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed